Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PFIZER LIMITED ( (IN:PFIZER) ) has issued an announcement.
Pfizer Limited’s board has recommended a final dividend of Rs 75 per equity share, representing 750% on a face value of Rs 10, for the financial year ended March 31, 2026. The move underscores the company’s strong financial performance and signals a commitment to shareholder returns through substantial cash distribution.
The company has set July 17, 2026 as the record date to determine shareholders eligible to receive the final dividend, aligning with regulatory requirements under SEBI’s listing regulations. Investors holding Pfizer Limited shares as of this date will be entitled to the payout, making the timeline a key consideration for existing and prospective shareholders in planning their positions.
More about PFIZER LIMITED
Pfizer Limited is an Indian pharmaceutical company focused on developing, manufacturing, and marketing prescription medicines and healthcare products. Operating within India’s regulated healthcare and capital markets, the company serves physicians, hospitals, and patients, while maintaining listings on major Indian stock exchanges for its equity shares.
Average Trading Volume: 11,709
Technical Sentiment Signal: Buy
Current Market Cap: 220.1B INR
For an in-depth examination of PFIZER stock, go to TipRanks’ Overview page.